Free Trial
NASDAQ:RCEL

Avita Medical (RCEL) Stock Price, News & Analysis

Avita Medical logo
$5.16 -0.14 (-2.64%)
Closing price 04:00 PM Eastern
Extended Trading
$5.17 +0.01 (+0.27%)
As of 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avita Medical Stock (NASDAQ:RCEL)

Key Stats

Today's Range
$5.06
$5.46
50-Day Range
$4.77
$6.28
52-Week Range
$4.71
$14.16
Volume
321,032 shs
Average Volume
256,245 shs
Market Capitalization
$136.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Moderate Buy

Company Overview

Avita Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

RCEL MarketRank™: 

Avita Medical scored higher than 19% of companies evaluated by MarketBeat, and ranked 837th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avita Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Avita Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Avita Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avita Medical is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avita Medical is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avita Medical has a P/B Ratio of 30.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avita Medical's valuation and earnings.
  • Percentage of Shares Shorted

    23.26% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 19.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Avita Medical has recently increased by 4.20%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Avita Medical does not currently pay a dividend.

  • Dividend Growth

    Avita Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    23.26% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 19.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Avita Medical has recently increased by 4.20%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Avita Medical this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for RCEL on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avita Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.80% of the stock of Avita Medical is held by insiders.

  • Percentage Held by Institutions

    Only 27.66% of the stock of Avita Medical is held by institutions.

  • Read more about Avita Medical's insider trading history.
Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter.

RCEL Stock News Headlines

One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
AVITA Medical, Inc. (RCEL) - Yahoo Finance
See More Headlines

RCEL Stock Analysis - Frequently Asked Questions

Avita Medical's stock was trading at $12.80 at the start of the year. Since then, RCEL shares have decreased by 59.7% and is now trading at $5.16.

Avita Medical Inc. (NASDAQ:RCEL) posted its quarterly earnings data on Thursday, May, 8th. The company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.39) by $0.14. The business had revenue of $18.51 million for the quarter, compared to the consensus estimate of $33.15 million. Avita Medical had a negative trailing twelve-month return on equity of 632.62% and a negative net margin of 79.61%.
Read the conference call transcript
.

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

Last Earnings
5/08/2025
Today
8/01/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:RCEL
CIK
1762303
Fax
N/A
Employees
130
Year Founded
2008

Price Target and Rating

High Price Target
$21.00
Low Price Target
$12.00
Potential Upside/Downside
+224.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.85 million
Net Margins
-79.61%
Pretax Margin
-79.56%
Return on Equity
-632.62%
Return on Assets
-71.72%

Debt

Debt-to-Equity Ratio
9.39
Current Ratio
2.09
Quick Ratio
1.72

Sales & Book Value

Annual Sales
$71.66 million
Price / Sales
1.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
29.92

Miscellaneous

Outstanding Shares
26,435,000
Free Float
25,695,000
Market Cap
$134.45 million
Optionable
Optionable
Beta
1.52

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:RCEL) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners